Yes, some have but has anyone looked into what these drugs were bought for / licensed in for? Because that is what we really need to be looking at. You also need to be looking at the competition within each of those indications to compare apples to apples. PPS will not be the only player within the OA market. Anyway, everyone is free to take their own view, this is just my one. Best of luck to everyone on either side of the fence.
Ann: Paradigm (PAR) Updated Investor Presentation, page-19
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.030(11.1%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 30.0¢ | 27.5¢ | $401.0K | 1.398M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 224067 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 109891 | 3 |
View Market Depth
| Last trade - 12.38pm 22/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
